Suzetrigine for agnosia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Why this status

  1. 3 Nov 2025: Trial started, NCT07226700
  2. 10 Nov 2025: Trial registered, NCT07226700

The trials

NCT07195669: RCT: Suzetrigine vs Norco for Post-op Pain

State
Not started
Phase
Phase 4
People
76 planned
Started
1 Oct 2025
Primary completion
30 Dec 2025
Arms
Suzetrigine + Ibuprofen
Results
None posted
  1. 29 Sep 2025: Trial registered

NCT07226700: Suzetrigine in Total Hip Arthroplasty

State
Under way
Phase
Phase 3
People
210 planned
Started
3 Nov 2025
Primary completion
1 Nov 2027
Arms
Suzetrigine
Results
None posted
  1. 3 Nov 2025: Trial started
  2. 10 Nov 2025: Trial registered

NCT07864896: Suzetrigine in TKA

State
Under way
Phase
Phase 3
People
148 planned
Started
15 Oct 2026
Primary completion
Jan 2029
Arms
Suzetrigine
Results
None posted
  1. 8 Oct 2026: Trial registered

NCT07866638: Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair

State
Not started
Phase
Phase 4
People
100 planned
Started
1 Nov 2026
Primary completion
1 Sep 2028
Arms
Treatment arm (n=50): Suzetrigine + Standard Multimodal Analgesia
Results
None posted
  1. 8 Oct 2026: Trial registered

NCT07905404: Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture

State
Not started
Phase
Phase 4
People
79 planned
Started
5 Jan 2027
Primary completion
30 Jul 2028
Arms
Suzetrigine + Standard Multimodal Analgesia
Results
None posted
  1. 29 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.